Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.
about
L-694,247: a potent 5-HT1D receptor agonistOn serotonin and migraine: a clinical and pharmacological reviewNeurogenic model of migraineNeuropeptides in migraine and cluster headacheCP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meningesOne hundred years of migraine research: major clinical and scientific observations from 1910 to 2010.The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation.Ergotamine and dihydroergotamine: a review.Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva.Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development.Emerging drugs in migraine treatment.Serotonergic agents in the management of cluster headache.Strategies for therapeutic hypometabothermiaSubcutaneous sumatriptan induces changes in frequency pattern in cluster headache patients.New concepts of vascular headache.Neuropeptide Y Y2 receptor-mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanismsCP-93,129, a potent and selective 5-HT1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea-pig dura mater.Time-dependent blockade of neurogenic plasma extravasation in dura mater by 5-HT1B/D agonists and endopeptidase 24.11.PACAP and migraine headache: immunomodulation of neural circuits in autonomic ganglia and brain parenchyma.
P2860
Q24685732-3482E173-B58B-49D5-A8F1-72361275E475Q28263827-DA92DAF6-CD63-471C-AD9C-49D1CFCF5D29Q28291139-1E16EFB2-8423-4067-9200-41104C84981EQ28305727-5FC5ED0A-4BE2-4CA3-9B5F-2960CD8E2543Q28326822-0B5338B7-3599-4FA0-A310-7C4365DF6C88Q34180539-CF353C42-D895-46C8-A26E-0608605A4D3CQ34373285-20E12A4A-2A0D-4C0F-9EC3-739AD3CCDFCDQ34530417-9242D1F5-D043-4932-ADA1-B103FECEFACEQ34662470-9E311564-8B24-418D-8D97-088F52C6C44DQ35026033-DFFE8E10-443F-4E10-8CF0-3E16A1D2EE42Q35027438-C3D4F3AB-D2DD-4E4D-AE3A-9EDD3B18D84DQ35189866-28422D3E-8F54-4B9C-BE4F-C410266002C7Q35602660-3766F935-A29B-412A-8073-91165706BF81Q37832687-6308B719-C128-4428-AB89-8F7B37AD4ED7Q38157908-D82915A9-D42A-42C7-A211-54A18D81D815Q39379377-5AA75A94-26DE-4645-AC3B-8DD0CE97CD24Q40850323-90689B8B-84F8-4F72-95C5-D39389D46C1BQ42581141-0C5C0EE7-3826-4FDF-854B-7FC89CAB4351Q42713037-63C2FC13-D79A-4E65-A761-C6AD7E1DA608Q42715132-CC0171C7-533A-4B4B-B412-589E6A7CD7A6Q52656846-787B0DB8-FE04-4008-8800-C479ED2ACCE6
P2860
Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Further characterization of th ...... travasation in rat dura mater.
@ast
Further characterization of th ...... travasation in rat dura mater.
@en
type
label
Further characterization of th ...... travasation in rat dura mater.
@ast
Further characterization of th ...... travasation in rat dura mater.
@en
prefLabel
Further characterization of th ...... travasation in rat dura mater.
@ast
Further characterization of th ...... travasation in rat dura mater.
@en
P2093
P2860
P1476
Further characterization of th ...... travasation in rat dura mater.
@en
P2093
M A Moskowitz
S J Peroutka
P2860
P304
P356
10.1111/J.1476-5381.1991.TB09805.X
P407
P577
1991-06-01T00:00:00Z